Search

Search Constraints

Begin New Search You searched for: Topic Health Remove constraint Topic: Health Publishing Institution Center for Global Development Remove constraint Publishing Institution: Center for Global Development

Search Results

1. Estimating Japan’s Return on Investment from an Ambitious Program to Incentivize New Antibiotics

2. Estimating the UK's Return on Investment from an Ambitious Program to Incentivize New Antibiotics

3. Estimating Canada’s Return on Investment from an Ambitious Program to Incentivize New Antibiotics

4. An Ambitious USG Advanced Commitment for Subscription-Based Purchasing of Novel Antimicrobials and Its Expected Return on Investment

5. The Next Game Changers: A Priority Innovation Agenda for Global Health

6. A Fund for Global Health Security and Pandemic Preparedness

7. Prioritizing Public Spending on Health in Lower-Income Countries: The Role of the Global Financing Facility for Women, Children and Adolescents

8. Meeting the Global Health Challenge to Reduce Death and Disability from Alcohol, Tobacco, and Sugar-Sweetened Beverage Consumption with Corrective Taxes

9. The Commitment to Development Index 2021

10. Exploring How the US International Development Finance Corporation Can Support Health Sector Investments: Is the Glass Half Full or Half Empty?

11. Addressing the COVID-19 Crisis’s Indirect Health Impacts for Women and Girls

12. Modicare Post-Election: Recommendations to Enhance the Impact of Public Health Insurance on UHC Goals in India

13. Understanding the Opportunity Cost, Seizing the Opportunity: Report of the Working Group on Incorporating Economics and Modelling in Global Health Goals and Guidelines

14. Removing Barriers and Closing Gaps: Improving Sexual and Reproductive Health and Rights for Rohingya Refugees and Host Communities

15. Imagining the Alternative Worlds of 2030: Policy Implications for the Future of Global Health Procurement

16. Tackling the Triple Transition in Global Health Procurement

17. Vaccine Introduction and Coverage in Gavi-Supported Countries 2015-2018: Implications for Gavi 5.0

18. Global Immunization and Gavi: Five Priorities for the Next Five Years

19. Tackling the Triple Transition in Global Health Procurement

20. UK Research Aid: Tied, Opaque and Off-Topic?

21. Five Things the Health Minister Should Do to Enhance the UK’s Global Health Footprint

22. Why Uncertainty in Global Health Interventions Matters—and What We Can Do About It

23. Strengthening European Leadership on Global Health Security

24. Development Impact Bonds Targeting Health Outcomes

25. The Face of African Infrastructure: Service Availability and Citizens' Demands

26. The Politics of Priority Setting in Health: A Political Economy Perspective

27. How Much Will Health Coverage Cost? Future Health Spending Scenarios in Brazil, Chile, and Mexico

28. To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda

29. The Health Financing Transition: A Conceptual Framework and Empirical Evidence

30. HIV/AIDS Intervention Packages in Five Countries: A Review of Budget Data

31. Commitment to Development Index 2013

32. Global Health and the New Bottom Billion: How Funders Should Respond to Shifts in Global Poverty and Disease Burden

33. Commitment to Development Index 2012

34. The Impact of Taxes and Social Spending on Inequality and Poverty in Argentina, Bolivia, Brazil, Mexico, and Peru: A Synthesis of Results

35. An Index of the Quality of Official Development Assistance in Health

36. State Health Insurance and Out-of-Pocket Health Expenditures in Andhra Pradesh, India

37. Getting Better Value for Money in Malaria Control

38. Priority-Setting in Health: Building Institutions for Smarter Public Spending

39. Quantifying the Quality of Health Aid: Health QuODA

40. CARMA Revisited: An Updated Database of Carbon Dioxide Emissions from Power Plants Worldwide

41. World Bank (ABCs of the IFIs Brief)

42. Affordable Interventions to Prevent Noncommunicable Diseases Worldwide

43. Global Health and the New Bottom Billion: What Do Shifts in Global Poverty and the Global Disease Burden Mean for GAVI and the Global Fund?

44. Achieving an AIDS Transition: Preventing Infections to Sustain Treatment

45. Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases

46. GAVI's Future: Steps to Build Strategic Leadership, Financial Sustainability, and Better Partnerships

47. The Best Things in Life are (Nearly) Free: Technology, Knowledge and Global Health

48. The Future of Development Finance

49. Focus UNFPA: Four Recommendations for Action

50. Find Me the Money: Financing Climate and Other Global Public Goods

51. The Health Systems Funding Platform: Resolving Tensions between the Aid and Development Effectiveness Agendas

52. Where Have All the Donors Gone? Scarce Donor Funding for Non-Communicable Diseases

53. IDA at 65: Heading Toward Retirement or a Fragile Lease on Life?

54. Every Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance

55. Ever Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance

56. The Race Against Drug Resistance

57. Bridging the Gap: Better, Faster, and Cheaper Clinical Trials for Health Products for Neglected Diseases

58. Think Long Term: How Global AIDS Donors Can Strengthen the Health Workforce in Africa

59. Start with a Girl: A New Agenda for Global Health

60. AIDS Treatment in South Asia: Equity and Efficiency Arguments for Shouldering the Fiscal Burden When Prevalence Rates Are Low

61. Rice Crisis Forensics: How Asian Governments Carelessly Set the World Rice Market on Fire

62. Going Beyond Gender as Usual: Why and How Global HIV/AIDS Donors Can Do More for Women and Girls

63. Performance Incentives for Global Health: Potential and Pitfalls

64. Making Markets for Merit Goods: The Political Economy of Antiretrovirals

65. Countering Drug Resistance in the Developing World: An Assessment of Incentives across the Value Chain and Recommendations for Policy Interventions

66. Making Markets for Merit Goods: The Political Economy of Antiretrovirals

67. Pricing and Access: Lessons from Randomized Evaluations in Education and Health

68. Performance-based Incentives for Health: Demand- and Supply-Side Incentives in the Nicaraguan Red de Protección Social - Working Paper 119

69. Performance-Based Incentives for Health: Conditional Cash Transfer Programs in Latin America and the Caribbean - Working Paper 120

70. Performance-Based Incentives for Health: Six Years of Results from Supply-Side Programs in Haiti - Working Paper 121

71. Performance-Based Incentives for Health: A Way to Improve Tuberculosis Detection and Treatment Completion?

72. Generation of Political Priority for Global Health Initiatives: A Framework and Case Study of Maternal Mortality

73. Generating Political Priority for Public Health Causes in Developing Countries: Implications From a Study on Maternal Mortality

74. Cost-Effective Prevention of Diarrheal Diseases: A Critical Review

75. Performance-based Incentives for Health: Demand- and Supply-Side Incentives in the Nicaraguan Red de Protección Social

76. Performance-Based Incentives for Health: Conditional Cash Transfer Programs in Latin America and the Caribbean

77. Performance-Based Incentives for Health: Six Years of Results from Supply-Side Programs in Haiti

78. Performance-Based Incentives for Health: A Way to Improve Tuberculosis Detection and Treatment Completion?

79. Do Visas Kill? Health Effects of African Health Professional Emigration

80. AIDS Treatment and Intrahousehold Resource Allocations: Children's Nutrition and Schooling in Kenya

81. New data on African health professionals abroad

82. A Policymakers' Guide to Dutch Disease

83. The Costs and Benefits of Front-loading and Predictability of Immunization

84. Governance and Corruption in Public Health Care Systems

85. Does the Private Sector Care About AIDS?